BEIJING, March 19, 2019 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a leading specialty hospital management solutions
provider and an operator of the largest network of radiotherapy and
diagnostic imaging centers in China, today announced three new appointments
to the management team.
Concord Medical's board of directors has appointed, effective
immediately:
- Mr. Yaw Kong Yap as the
President of the Company. Mr. Yap will continue to serve as Concord
Medical's Chief Financial Officer;
- Ms. Xiao Fu as the Chief
Operating Officer; and
- Dr. Matthew D. Callister as the
Chief Medical Officer.
Mr. Yap previously served as a Senior Vice President of the
Company from 2008 to July 2014 and
has been serving as the Company's Chief Financial Officer since
then. He served as a director and the financial controller of the
Company from 2008 to 2011, the Chief Financial Officer of China
Medstar in 2005 and the Chief Executive Officer of Advanced Produce
Centre Development Pte, Ltd. in 2003. Mr. Yap graduated from the
Indiana University of Pennsylvania in
the United States with a
bachelor's degree in 1990. Mr. Yap is a Certified Public Accountant
in the United States.
Ms. Xiao Fu has served as a
Senior Vice President of the Company since July 2009. Ms. Xiao
Fu joined China Medstar in 1997 and served as its Senior
Vice President prior to Concord Medical's acquisition of China
Medstar. Prior to joining China Medstar, Ms. Xiao Fu served as a Sales Supervisor of
Rhone-Poulenc Rorer from 1995 to December
1997. Ms. Xiao Fu graduated
from the Shanghai Second Military Medical University in 1986,
majoring in Healthcare.
Dr. Matthew D. Callister joined Concord Medical in
March 2019. Prior to joining Concord
Medical, Dr. Callister served as the Senior Physician Executive of
Banner MD Anderson Cancer Center and Service Line in 2014, the
Division Chief of Radiation Oncology at Banner MD Anderson
Cancer Center in 2011 and a Consultant at the Department of
Radiation Oncology of Mayo Clinic Arizona in 2004. Dr. Callister
has been an Adjunct Associate Professor of Radiation Oncology at
the UT-MD Anderson Cancer Center from 2011 to present. Dr.
Callister received a Doctor of Medicine degree from the
Duke University School of Medicine in
1997.
"We are very pleased to appoint Mr. Yaw Kong Yap as
Concord Medical's President, Ms. Xiao Fu as our Chief
Operating Officer and Dr. Matthew D.
Callister as our Chief Medical Officer," said Dr. Jianyu Yang, Chairman and
CEO of Concord Medical. "Each brings a wealth of professional
leadership, academic excellence and business experience to Concord
Medical. We look forward to working closely with them to execute
our growth initiatives and create added value for our
shareholders."
About Concord Medical
Concord Medical Services Holdings Limited is a leading specialty
hospital management solutions provider and an operator of the
largest network of radiotherapy and diagnostic imaging centers in
China. As of June 30, 2018, the Company operated a network of
30 centers with 21 hospital partners that spanned 21 cities and 14
provinces and administrative regions in China. Under long-term arrangements with
top-tier hospitals in China, the
Company provides radiotherapy and diagnostic imaging equipment to
and manages the daily operations of these centers, which are
located on the premises of its hospital partners. The Company also
provides ongoing training to doctors and other medical
professionals in its network of centers to ensure a high level of
clinical care for patients. For more information, please see
http://ir.ccm.cn.
View original
content:http://www.prnewswire.com/news-releases/concord-medical-announces-new-appointments-to-management-team-300814634.html
SOURCE Concord Medical Services Holdings Limited